Not exact matches
While some
psychotic symptoms can be reasonably well treated with medication,
patients often still have debilitating problems with memory and cognitive function, meaning they struggle to get back to work or stay in education.
At discharge the
patient can be well, have full mental capacity, with greatly reduced
psychotic symptoms, or even none at all.
After his six - month trial ended, however, several
patients in the treatment group became
psychotic, raising the question of whether the treatment was preventing schizophrenia or simply controlling its
symptoms.
Psychotic symptoms are reasonably well treated by current medications; however,
patients are still left with debilitating cognitive impairments, including in their memory, and so are frequently unable to return to university or work.
The attenuation of MP's effects could also reflect abnormal D2 receptor function, as was previously suggested to explain findings in marijuana - abusing schizophrenic
patients, who, despite displaying low DA release, showed increases in
psychotic symptoms when challenged with amphetamine (21).
In psychiatric in -
patients, caffeine has been found to increase anxiety, hostility and
psychotic symptoms.
«The approval of Fanapt ™ marks a new opportunity for many
patients with schizophrenia, who experience only partial responses to current therapies, to achieve better control of their
symptoms,» remarked Dr. Peter J. Weiden, Professor of Psychiatry and Director of the
Psychotic Disorders Program at the University of Illinois at Chicago.
Patients with
psychotic symptoms should undergo a thorough physical examination and detailed
patient history to rule out organic causes of the psychosis (such as brain tumor).
Patients in the family intervention group had better functioning on activities of daily living than patients in the 2 control groups, but did not differ for cognitive function, depression, psychotic symptoms, behavioural disturbances, or overall severity of d
Patients in the family intervention group had better functioning on activities of daily living than
patients in the 2 control groups, but did not differ for cognitive function, depression, psychotic symptoms, behavioural disturbances, or overall severity of d
patients in the 2 control groups, but did not differ for cognitive function, depression,
psychotic symptoms, behavioural disturbances, or overall severity of dementia.
A trial of two cognitive - behavioural methods of treating drug - resistant residual
psychotic symptoms in schizophrenic
patients.
Objectives: To investigate whether intensive cognitive behaviour therapy results in significant improvement in positive
psychotic symptoms in
patients with chronic schizophrenia.
The following hypotheses were tested: that the cognitive behaviour therapy would be superior to supportive counselling and routine care, and routine care alone, firstly, in reducing positive
psychotic symptoms; secondly, in preventing the exacerbation of positive
symptoms and reducing hospital stay; and, thirdly, by using the convention of the previous study of 50 % improvement in positive
symptoms as an indicator of considerable clinical improvement, 6 in the number of
patients achieving such improvement.
Because an improvement of 50 % or more in
psychotic symptoms represents such an important clinical change in
patients with chronic schizophrenia a logistic regression was performed to investigate which variables contributed to this improvement.
Many
patients continue to experience persistent positive
psychotic symptoms, hallucinations, and delusions, which are disabling and distressing.
Measures utilized include the Diagnostic Infant and Preschool Assessment (DIPA), the Trauma
Symptom Checklist for Young Children, the Clinical Global Impression — Severity (CGI), the Clinical Global Impression — Improvement (CGI — Improvement), the Structured Clinical Interview for DSM - IV - TR Axis I Disorders, Research Version,
Patient Edition With
Psychotic Screen (SCID - RV), the Expectancy Rating Form, and the Client Satisfaction Questionnaire.
We investigated the relation between ChM and
psychotic symptoms, taking into account levels of (insecure) attachment, in 131
patients with
psychotic illness, 123 siblings and 72 controls.
A trial of two cognitive - behavioural methods of treating drug - resistant
psychotic symptoms in schizophrenic
patients: I. Outcome
In the realm of trait variables, in a longitudinal study of stable outpatients involving an initial assessment and a 9 - mo follow - up session, 24 those who scored high on a self - report measure of trait anxiety at the initial assessment and who experienced one or more «independent» stressful life events (ie, events not caused by
patient behavior) during the month prior to the follow - up session showed significant increases in
psychotic symptoms compared with those who either were low in trait anxiety or had no independent stressful life events.
An insecure attachment style has been reported in association with
psychotic symptoms in both nonclinical41 — 46 and
patient samples.47, 48 Although these findings are based on cross-sectional comparisons in which participants» current styles of relating to others are assessed rather than the quality of past relationships, prospective data suggest that disrupted attachment relations may be causal.